Table 1 General characteristics and health statuses of the participants.

Male

73

51.4

Female

69

48.6

Age of children (years)

12.3

1.8

12.3

12.3

0.87

<11

21

14.8

11

22

15.5

12

30

21.1

13

26

18.3

14

27

19.0

15

16

11.3

Duration under antiretroviral therapy (years)

4.9

3.3

4.6

5.1

0.30

CD4 + cell count (cells/mm³)

840.1

286.9

870.6

811.2

0.22

Body mass index for age

−1.24

1.15

−0.93

−1.53

<0.01**

Normal: 1 to −2SD

110

77.5

Underweight: <−2SD

23

16.2

Severely underweight: <−3SD

8

5.6

Height-for-age

−2.02

1.17

−1.98

−2.06

0.71

Overall health-related quality of life

75.7

12.8

73.8

77.5

0.08

Physical health

77.6

16.8

Emotional functioning

72.3

17.1

Social functioning

82.1

16.0

School functioning

69.6

16.9

Abdominal/stomach pain

89

62.7

65.2

60.3

0.54

Headache

85

59.9

67.1

53.4

0.094

Dry or painful mouth/trouble swallowing

77

53.8

59.4

49.3

0.23

Physical or bodily pain

72

50.7

48.5

53.4

0.56

Nausea/vomiting

73

51.0

47.8

54.8

0.41

Diarrhoea

70

49.0

40.6

57.5

0.04*

Dizziness/light-headedness

58

40.6

44.9

37.0

0.34

Fevers/night sweats/shaking/chills

54

38.0

44.9

31.5

0.10

Chest pain/tightness

46

32.4

29.0

35.6

0.40

DMFT score

4.3

3.3

4.5

4.2

0.54

Debris index

1.8

0.5

1.6

1.9

<0.01**

Salivary pH

5.7

0.6

5.6

5.8

0.03*

Salivary flow (mL/min)

0.5

0.3

0.5

0.5

0.59

Oral health-related quality of life

15.9

8.7

16.6

15.1

0.32